Expert Interview
A Third Look: Discussing the recent label update for SYFOVRE (pegcetacoplan injection) addressing cases of eye inflammation and blockage in a retinal vein in patients who have received the drug.
Ticker(s): APLSInstitution: University of Miami
- Professor of Ophthalmology at University of Miami
- Manages 60 patients with GA and has prescribed syfovre to 35 patients
- Areas of expertise include Diabetic Retinopathy, Macular Degeneration, Macular Diseases, Vitreoretinal Diseases and Surgery; Retinal Complications of Cataract Surgery
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
